Multiple Myeloma Patients Ineligible for Randomized Controlled Trials Have Poorer Outcomes Irrespective of Treatment

Mary Kate Malecek; Mark Fiala; Mark Schroeder; James Dukeman; Armin Ghobadi; Keith Stockerl-Goldstein; Tanya Wildes; Ravi Vij

doi:10.1016/j.clml.2018.06.008

Multiple Myeloma Patients Ineligible for Randomized Controlled Trials Have Poorer Outcomes Irrespective of Treatment

Mary Kate Malecek
, Mark Fiala
, Mark Schroeder
, James Dukeman
, Armin Ghobadi
, Keith Stockerl-Goldstein
, Tanya Wildes
, Ravi Vij

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	e363-e364
Journal	Clinical Lymphoma, Myeloma and Leukemia
Volume	18
Issue number	9
DOIs	https://doi.org/10.1016/j.clml.2018.06.008
State	Published - Sep 2018

Access to Document

10.1016/j.clml.2018.06.008

Cite this

@article{f2d0cdba3d5f48a08d0de136bdd3e56b,

title = "Multiple Myeloma Patients Ineligible for Randomized Controlled Trials Have Poorer Outcomes Irrespective of Treatment",

author = "Malecek, \{Mary Kate\} and Mark Fiala and Mark Schroeder and James Dukeman and Armin Ghobadi and Keith Stockerl-Goldstein and Tanya Wildes and Ravi Vij",

year = "2018",

month = sep,

doi = "10.1016/j.clml.2018.06.008",

language = "English",

volume = "18",

pages = "e363--e364",

journal = "Clinical Lymphoma, Myeloma and Leukemia",

issn = "2152-2650",

number = "9",

}

TY - JOUR

T1 - Multiple Myeloma Patients Ineligible for Randomized Controlled Trials Have Poorer Outcomes Irrespective of Treatment

AU - Malecek, Mary Kate

AU - Fiala, Mark

AU - Schroeder, Mark

AU - Dukeman, James

AU - Ghobadi, Armin

AU - Stockerl-Goldstein, Keith

AU - Wildes, Tanya

AU - Vij, Ravi

PY - 2018/9

Y1 - 2018/9

UR - https://www.scopus.com/pages/publications/85051404431

U2 - 10.1016/j.clml.2018.06.008

DO - 10.1016/j.clml.2018.06.008

M3 - Letter

C2 - 30001984

AN - SCOPUS:85051404431

SN - 2152-2650

VL - 18

SP - e363-e364

JO - Clinical Lymphoma, Myeloma and Leukemia

JF - Clinical Lymphoma, Myeloma and Leukemia

IS - 9

ER -

Multiple Myeloma Patients Ineligible for Randomized Controlled Trials Have Poorer Outcomes Irrespective of Treatment

Access to Document

Other files and links

Cite this